Search details
1.
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Circulation
; 121(16): 1809-17, 2010 Apr 27.
Article
in English
| MEDLINE | ID: mdl-20385930
2.
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial.
Eur Heart J
; 31(17): 2097-102, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20400762
3.
Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Eur Heart J
; 31(17): 2103-10, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20413397
4.
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.
Eur Heart J
; 31(16): 1993-2005, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20558431
5.
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Circulation
; 119(15): 2032-9, 2009 Apr 21.
Article
in English
| MEDLINE | ID: mdl-19349325
6.
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Circulation
; 119(21): 2758-64, 2009 Jun 02.
Article
in English
| MEDLINE | ID: mdl-19451347
7.
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
Lancet
; 373(9665): 723-31, 2009 Feb 28.
Article
in English
| MEDLINE | ID: mdl-19249633
8.
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.
Lancet
; 374(9692): 787-95, 2009 Sep 05.
Article
in English
| MEDLINE | ID: mdl-19717184
9.
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
N Engl J Med
; 357(20): 2001-15, 2007 Nov 15.
Article
in English
| MEDLINE | ID: mdl-17982182
10.
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
Am Heart J
; 160(4): 635-41, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20934556
11.
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
Eur Heart J
; 30(14): 1753-63, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19435740
12.
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation
; 118(16): 1626-36, 2008 Oct 14.
Article
in English
| MEDLINE | ID: mdl-18757948
13.
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Lancet
; 371(9621): 1353-63, 2008 Apr 19.
Article
in English
| MEDLINE | ID: mdl-18377975
14.
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
N Engl J Med
; 354(14): 1477-88, 2006 Apr 06.
Article
in English
| MEDLINE | ID: mdl-16537665
15.
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.
Am Heart J
; 157(3): 517-24, 2009 Mar.
Article
in English
| MEDLINE | ID: mdl-19249423
16.
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
Am Heart J
; 157(4): 673-9.e1, 2009 Apr.
Article
in English
| MEDLINE | ID: mdl-19332194
17.
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
Am Heart J
; 158(3): 335-341.e3, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19699854
18.
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial.
J Thromb Thrombolysis
; 27(4): 359-64, 2009 May.
Article
in English
| MEDLINE | ID: mdl-18535785
19.
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial.
Eur Heart J
; 29(20): 2473-9, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18682445
20.
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Circulation
; 116(15): 1647-52, 2007 Oct 09.
Article
in English
| MEDLINE | ID: mdl-17804441